Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
98,440,265
-
Share change
-
+20,369,405
-
Total reported value
-
$305,248,899
-
Put/Call ratio
-
127%
-
Price per share
-
$3.10
-
Number of holders
-
98
-
Value change
-
+$64,179,450
-
Number of buys
-
75
-
Number of sells
-
21
Institutional Holders of VBI VACCINES INC CDA - COM NEW (VBIV) as of Q2 2020
As of 30 Jun 2020,
VBI VACCINES INC CDA - COM NEW (VBIV) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
98,440,265 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Cambridge Investment Research Advisors, Inc., TWO SIGMA INVESTMENTS, LP, GENERAL AMERICAN INVESTORS CO INC, and CITADEL ADVISORS LLC.
This page lists
98
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.